|
|
 |
|
Viewing report
|
|
 |
 |
Belgium Pharmaceutical Market Analysis, 2010-2014
Venn Research Inc., Aug 2010, Pages: 106
Having displayed quite healthy growth rates in the years 2005-2009 the Belgium pharmaceuticals market is expected to decelerate significantly in 2010 followed by the slow and graduate decrease in growth in the years up to 2014.
The Belgium pharmaceuticals market generated total revenues of $6,415.8 million in 2009, representing a compound annual growth rate (CAGR) of 5.6% for the period spanning 2005-2009. In comparison, the French and German markets grew with CAGRs of 3.2% and 3.1% respectively, over the same period, to reach respective values of $37,306.2 million and $37,139.2 million in 2009.
Cardiovascular sales proved the most lucrative for the Belgian pharmaceuticals market in 2009, gene-rating total revenues of $1,412.9 million, equivalent to 22% of the market's overall value. In comparison, sales of central nervous system generated revenues of $1,010.2 million in 2009, equating to 15.7% of the market's aggregate revenues.
This report highlights the Belgium pharmaceutical sector in terms of market share, key trends, market players and competitive scenario in the market.
Key Highlights: - Current market scenario of Belgium pharmaceutical market, by revenue, geographic regions, product types, and market players. - Competitive analysis of the pharmaceutical sector by each country via-a-vis global market - Market forecast of Belgium Pharmaceuticals market, by revenue till 2014. - Covered more than 12 company profiles in the pharmaceutical sector covering their performance, key financials, SWOT analysis, and investment analysis.
Venn Research, in association to its network of partners provides information and research to thousands of clients worldwide. The information provided herein has been obtained from reliable sources to provide a holistic survey on the market dynamics.
Customers who bought this item also bought
Netherlands Pharmaceutical Market Analysis, 2010-2014
Italy Pharmaceutical Market Analysis, 2010-2014
France Pharmaceutical Market Analysis, 2010-2014
Denmark Pharmaceutical Market Analysis, 2010-2014
Hungary Pharmaceutical Market Analysis, 2010-2014
Czech Republic Pharmaceutical Market Analysis, 2010-2014
Poland Pharmaceutical Market Analysis, 2010-2014
Germany Pharmaceutical Market Analysis, 2010-2014
Spain Pharmaceutical Market Analysis, 2010-2014
Russia Pharmaceutical Market Analysis, 2010-2014
|
 |
|
|